MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

Related Keywords

University Of Texas ,Texas ,United States ,Bellicum Go ,Katy Rezvani ,Philip Jones ,Cancer Center ,Drug Administration ,Research Strategy ,Bellicum Pharmaceuticals Inc ,Manderson Cancer ,Bellicum Pharmaceuticals ,Therapeutics Discovery ,Stem Cell Transplantation ,Cell ,Iopharmaceutical ,Dancer ,Nzyme ,Mh ,Pharmaceuticals ,Technology ,Humor ,